Skip to main content
Premium Trial:

Request an Annual Quote

VC Investor Launches $125M Life Sciences Fund

NEW YORK (GenomeWeb News) – Excel Venture Management, a venture capital firm based in Boston, announced today that it has launched the Excel Medical Fund with $125 million to be invested in early- to late-stage life science platform companies.

Excel said that the new fund will focus its investments on healthcare information technology, services, diagnostics, medical devices, and life sciences platforms with applicability to adjacent industries such as energy, chemicals, defense, and agriculture.

The new fund also has already established investments in two genomics industry players: BioTrove and Synthetic Genomics.

The investment team for the fund includes Managing Directors Rick Blume, Steven Gullans, Juan Enriquez, and Enrico Petrillo; Venture Partner Donald Crothers; and Vice Presidents Caleb Winder and Tricia Moriarty.

"Excel's portfolio will be balanced across the many interrelated sectors that are impacted by life science technologies," Enriquez said in a statement. "The rapid adoption and expansion of these technologies into major industries such as energy, chemicals, defense, and agriculture represents an enormous investment opportunity. We believe that we are just seeing the tip of the iceberg."

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.